Canada’s in-house synthetic drug production ramped up in 2019, when China placed restrictions on exports of processed fentanyl, and took off further when COVID lockdowns interrupted the cross-border flow of goods in the early 2020s.
Large-scale fentanyl labs first sprung up in British Columbia...